---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-087921"
form_type: "8-K"
ticker: "RAPP"
cik: "0002012593"
company_name: "Rapport Therapeutics, Inc."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:40:00.935714+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Rapport Therapeutics stockholders re-elect three Class I directors and ratify PwC as auditor

## Summary
- Reid Huber, Ph.D., John Maraganore, Ph.D., and Wendy B. Young, Ph.D. elected as Class I directors for terms expiring 2028.
- Director votes: Huber 31,146,580 for; Maraganore 31,222,571 for; Young 31,783,990 for.
- Ratification of PricewaterhouseCoopers LLP as independent auditor passed with 32,804,657 votes for, 112,489 against.
- Meeting held June 17, 2025; 36,497,555 shares outstanding and entitled to vote.

## SEC filing metadata
- accession: 0000950170-25-087921
- form_type: 8-K
- ticker: RAPP
- cik: 0002012593
- company_name: Rapport Therapeutics, Inc.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2012593/000095017025087921/0000950170-25-087921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2012593/000095017025087921/rapp-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-087921
- JSON: https://secwatch.observer/filing/0000950170-25-087921.json
- Plain text: https://secwatch.observer/filing/0000950170-25-087921.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.